How do sermorelin and ipamorelin compare?

Both sermorelin and ipamorelin prompt your pituitary to release your own growth hormone, but they use different signals. In a small 16-week trial in adults 55 to 71, nightly sermorelin raised nighttime growth hormone and IGF-1, a downstream growth signal, men gained an average 1.26 kg of lean mass and reported better well-being and libido, and skin measured thicker in men and women Atlas summary of Khorram trial. Ipamorelin works through the ghrelin receptor instead and is valued for a selective pulse that did not raise cortisol, prolactin or ACTH Drip Gym comparison.

How do sermorelin and ipamorelin work differently?

Sermorelin copies part of GHRH, the brain hormone that tells your pituitary to release growth hormone. It contains 29 amino acids, the building blocks of protein, and it switches on the GHRH receptor Drip Gym comparison.

Ipamorelin is much smaller, with five amino acids, and it switches on a separate ghrelin receptor that also tells your pituitary to release a pulse of growth hormone. In the published hormone study, ipamorelin did not significantly raise cortisol, prolactin or ACTH, a pituitary signal tied to cortisol, which sets it apart from less selective peptides such as GHRP-6 and GHRP-2 European Journal of Endocrinology study.

Sermorelin has the longer drug history. Brand Geref was approved for growth hormone deficiency in children and for testing pituitary growth hormone reserve, then the maker stopped selling it in 2008. In 2013 the FDA stated the withdrawal was not for safety or effectiveness reasons Federal Register notice.

What changed for body, skin, and libido in human studies?

In the 16-week trial, 19 men and women ages 55 to 71 used nightly sermorelin. Nighttime growth hormone and IGF-1 rose in both sexes. Men gained an average 1.26 kg of lean mass, skin thickness increased in men and women when measured, and men reported better general well-being and libido Atlas summary of Khorram trial.

Those libido and well-being reports came only from men in that small older group, so they do not show what women 30 to 55 will feel. A review of growth hormone secretagogues in men noted they are potent stimulators of growth hormone and IGF-1 that may improve body composition and symptoms like fat gain and muscle loss, but said clinical efficacy data remain largely lacking PubMed review.

For IGF-1 size, a 2026 provider comparison estimates 10 to 25 percent rises in responders for sermorelin and 15 to 30 percent for ipamorelin, and it notes sermorelin has older randomized trial data while ipamorelin data are mostly observational. Treat those ranges as rough estimates, not promises PlexusDx comparison.

Which option fits low energy or low libido and how do you start?

If low drive or flat energy is your main concern, sermorelin has the only direct human report here, better well-being and libido in older men, plus measured gains in lean mass and skin thickness. Ipamorelin has no matching libido report in the research reviewed here, but its appeal is a cleaner growth hormone pulse without extra cortisol or prolactin.

Because they act on separate receptors, researchers describe them as complementary rather than the same treatment. Your choice comes down to whether you want the treatment with a small older libido and body composition report or the treatment with a more selective hormone signal.

To see which plan fits your history and goals, take the HOD quiz at HOD quiz. HOD reviews your answers and, when appropriate, connects you to its own clinician-led plan through its website.